Type 2 Diabetes Mellitus and Alzheimer’s Disease: Role of Insulin Signalling and Therapeutic Implications
In the last two decades, numerous in vitro studies demonstrated that insulin receptors and theirs downstream pathways are widely distributed throughout the brain. This evidence has proven that; at variance with previous believes; insulin/insulin-like-growth-factor (IGF) signalling plays a crucial ro...
Main Authors: | Andrea Tumminia, Federica Vinciguerra, Miriam Parisi, Lucia Frittitta |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/19/11/3306 |
Similar Items
-
Differential involvement of insulin receptor substrate (IRS)-1 and IRS-2 in brain insulin signaling is associated with the effects on amyloid pathology in a mouse model of Alzheimer's disease
by: Toshitaka Ochiai, et al.
Published: (2021-11-01) -
The Implication of the Brain Insulin Receptor in Late Onset Alzheimer’s Disease Dementia
by: Jaume Folch, et al.
Published: (2018-01-01) -
Insulin and Insulin Resistance in Alzheimer’s Disease
by: Aleksandra Sędzikowska, et al.
Published: (2021-09-01) -
MicroRNAs as Regulators of Insulin Signaling: Research Updates and Potential Therapeutic Perspectives in Type 2 Diabetes
by: Laura Nigi, et al.
Published: (2018-11-01) -
The Insulin Receptor: A Potential Target of Amarogentin Isolated from <i>Gentiana rigescens</i> Franch That Induces Neurogenesis in PC12 Cells
by: Lihong Cheng, et al.
Published: (2021-05-01)